I don't think it goes beyond V, they have a contract for HIV-1 only. I think Leronlimab in the cancers world will become very popular and sought before it is approved for cancers . But again I emphasize, it rarely happens that a drug that will soon be approved for one indication, meanwhile get BTD for cancer, has already been tested and underwent all the approval procedures, Leronlimab could be approved for cancers in record time.